Fusion Antibodies (LON:FAB) Stock Price Down 12.7% – Time to Sell?

Fusion Antibodies plc (LON:FAB)’s share price was down 12.7% on Thursday . The company traded as low as GBX 7.68 ($0.09) and last traded at GBX 7.68 ($0.09). Approximately 1,231,095 shares changed hands during trading, a decline of 54% from the average daily volume of 2,684,324 shares. The stock had previously closed at GBX 8.80 ($0.11).

Fusion Antibodies Trading Up 6.3 %

The company has a market cap of £8.11 million, a PE ratio of -212.50 and a beta of 0.49. The business has a 50 day simple moving average of GBX 6.43 and a two-hundred day simple moving average of GBX 4.58. The company has a current ratio of 3.87, a quick ratio of 2.36 and a debt-to-equity ratio of 2.40.

Fusion Antibodies Company Profile

Fusion is a Belfast based contract research organisation (“CRO”) providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.

The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation.